Your browser doesn't support javascript.
loading
High Levels of Perivascular Inflammation and Active Demyelinating Lesions at Time of Death Associated with Rapidly Progressive Multiple Sclerosis Disease Course: A Retrospective Postmortem Cohort Study.
Nicholas, Richard; Magliozzi, Roberta; Marastoni, Damiano; Howell, Owain; Roncaroli, Federico; Muraro, Paolo; Reynolds, Richard; Friede, Tim.
Affiliation
  • Nicholas R; Imperial College Healthcare NHS Trust, London, UK.
  • Magliozzi R; Department of Brain Sciences, UK Multiple Sclerosis Society Tissue Bank, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, UK.
  • Marastoni D; Department of Brain Sciences, UK Multiple Sclerosis Society Tissue Bank, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, UK.
  • Howell O; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
  • Roncaroli F; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
  • Muraro P; Department of Brain Sciences, UK Multiple Sclerosis Society Tissue Bank, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, UK.
  • Reynolds R; Institute for Life Sciences, Swansea University, Swansea, UK.
  • Friede T; Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK.
Ann Neurol ; 95(4): 706-719, 2024 Apr.
Article in En | MEDLINE | ID: mdl-38149648
ABSTRACT

OBJECTIVE:

Analysis of postmortem multiple sclerosis (MS) tissues combined with in vivo disease milestones suggests that whereas perivascular white matter infiltrates are associated with demyelinating activity in the initial stages, leptomeningeal immune cell infiltration, enriched in B cells, and associated cortical lesions contribute to disease progression. We systematically examine the association of inflammatory features and white matter demyelination at postmortem with clinical milestones.

METHODS:

In 269 MS brains, 20 sites were examined using immunohistochemistry for active lesions (ALs) and perivenular inflammation (PVI). In a subset of 22, a detailed count of CD20+ B cells and CD3+ T cells in PVIs was performed.

RESULTS:

ALs were detected in 22%, whereas high levels of PVI were detected in 52% of cases. ALs were present in 35% of cases with high levels of PVI. Shorter time from onset of progression to death was associated with increased prevalence and higher levels of PVI (both p < 0.0001). Shorter time from onset of progression to wheelchair use was associated with higher prevalence of ALs (odds ratio [OR] = 0.921, 95% confidence interval [CI] = 0.858-0.989, p = 0.0230) and higher level of PVI (OR = 0.932, 95% CI = 0.886-0.981, p = 0.0071). High levels of PVI were associated with meningeal inflammation and increased cortical demyelination and significantly higher levels of B lymphocytes within the PVI.

INTERPRETATION:

ALs, a feature of early disease stage, persist up to death in a subgroup with high levels of PVI. These features link to a rapid progressive phase and higher levels of meningeal inflammation and B-cell infiltrates, supporting the hypothesis that chronic inflammation drives progression in MS. ANN NEUROL 2024;95706-719.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Chronic Progressive / Multiple Sclerosis Limits: Humans Language: En Journal: Ann Neurol Year: 2024 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Chronic Progressive / Multiple Sclerosis Limits: Humans Language: En Journal: Ann Neurol Year: 2024 Type: Article Affiliation country: United kingdom